Adalta Ltd
About
Adalta Ltd is a biotechnology company focused on the discovery and development of its proprietary i-body technology platform. The company is engaged in developing a pipeline of i-body enabled therapeutics for the treatment of fibrotic diseases, including idiopathic pulmonary fibrosis. Adalta's operations include research and development activities aimed at advancing its lead product candidates through preclinical and clinical stages.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- 1AD
Related Shares
Algorae Pharmaceuticals Ltd
Biotechnology
Actinogen Medical Ltd
Biotechnology
Argenica Therapeutics Ltd
Biotechnology
Arovella Therapeutics Ltd
Biotechnology
Anagenics Ltd
Biotechnology
Anatara Lifesciences Ltd
Biotechnology
Investor Resources
Should you buy Adalta Ltd right now?
While 1AD looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now